Eric Devroe
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | $528,745 | $1,358,003 |
| 2024 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | $510,467 | $1,146,728 |
| 2023 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | — | — |
| 2022 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | $386,779 | $2,179,897 |
| 2021 | Acrivon Therapeutics, Inc. (ACRV) | Chief Operating Officer | $300,000 | $462,939 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.